Whilst it is evident that orexin may be important in headache pathophysiology and therefore as a potential therapeutic target, very few clinical studies have been conducted based on orexin, despite their approval and efficacy for associated conditions such as insomnia and narcolepsy [63,140,141]. The gene discussed is HCRT; the disease is insomnia.